Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Jose Lopez Furst"'
Autor:
Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Galia Rahav, Amy J. Mathers, Matteo Bassetti, Jose Vazquez, Oliver A. Cornely, Joseph Solomkin, Tanaya Bhowmick, Jihad Bishara, George L. Daikos, Tim Felton, Maria Jose Lopez Furst, Eun Jeong Kwak, Francesco Menichetti, Ilana Oren, Elizabeth L. Alexander, David Griffith, Olga Lomovskaya, Jeffery Loutit, Shu Zhang, Michael N. Dudley, Keith S. Kaye
Publikováno v:
Infectious Diseases and Therapy, Vol 7, Iss 4, Pp 439-455 (2018)
Abstract Introduction Treatment options for carbapenem-resistant Enterobacteriaceae (CRE) infections are limited and CRE infections remain associated with high clinical failure and mortality rates, particularly in vulnerable patient populations. A Ph
Externí odkaz:
https://doaj.org/article/106733a022be48b9ab7ef1601be3b1a5
Autor:
Michael N. Dudley, Jihad Bishara, George L. Daikos, Matteo Bassetti, Amy J. Mathers, Jeffery Loutit, Galia Rahav, Jose A. Vazquez, David E. Griffith, Keith S Kaye, Shu Zhang, Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Tanaya Bhowmick, Oliver A. Cornely, Olga Lomovskaya, Timothy Felton, Joseph S. Solomkin, Francesco Menichetti, Maria Jose Lopez Furst, Elizabeth Alexander, Eun J. Kwak, Ilana Oren
Publikováno v:
Infectious Diseases and Therapy, Vol 7, Iss 4, Pp 439-455 (2018)
Infectious Diseases and Therapy
Wunderink, R G, Giamarellos-Bourboulis, E J, Rahav, G, Mathers, A J, Bassetti, M, Vazquez, J, Cornely, O A, Solomkin, J, Bhowmick, T, Bishara, J, Daikos, G L, Felton, T, Furst, M J L, Kwak, E J, Menichetti, F, Oren, I, Alexander, E L, Griffith, D, Lomovskaya, O, Loutit, J, Zhang, S, Dudley, M N & Kaye, K S 2018, ' Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections : The TANGO II Randomized Clinical Trial ', Infectious diseases and therapy . https://doi.org/10.1007/s40121-018-0214-1
Infectious Diseases and Therapy
Wunderink, R G, Giamarellos-Bourboulis, E J, Rahav, G, Mathers, A J, Bassetti, M, Vazquez, J, Cornely, O A, Solomkin, J, Bhowmick, T, Bishara, J, Daikos, G L, Felton, T, Furst, M J L, Kwak, E J, Menichetti, F, Oren, I, Alexander, E L, Griffith, D, Lomovskaya, O, Loutit, J, Zhang, S, Dudley, M N & Kaye, K S 2018, ' Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections : The TANGO II Randomized Clinical Trial ', Infectious diseases and therapy . https://doi.org/10.1007/s40121-018-0214-1
Introduction Treatment options for carbapenem-resistant Enterobacteriaceae (CRE) infections are limited and CRE infections remain associated with high clinical failure and mortality rates, particularly in vulnerable patient populations. A Phase 3, mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358dd5f268beecda29dcf910a4c993bc
http://hdl.handle.net/11568/946379
http://hdl.handle.net/11568/946379
Autor:
María José López Furst, Lautaro de Vedia, Silvina Fernández, Noella Gardella, María Cristina Ganaha, Sergio Prieto, Edith Carbone, Nicolás Lista, Flavio Rotryng, Graciana I Morera, Marta Mollerach, Martín E Stryjewski, Grupo de Estudio de Infecciones de Piel y Estructuras Relacionadas por Staphylococcus aureus meticilino-resistente de la Comunidad, Sociedad Argentina de Infectología
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78303 (2013)
BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is now the most common cause of skin and skin structure infections (SSSI) in several world regions. In Argentina prospective, multicenter clinical studies have onl
Externí odkaz:
https://doaj.org/article/f05a7859573b44a48d61dfaa402d4706